
Traumatic Brain Injury Market To Expand At A CAGR Of 10.9% During The Study Period (2020-2034) Fueled By Advances In ...
(MENAFN- PR Newswire) Pharmaceutical companies have made significant investments in traumatic brain injury drug development, although the late-stage pipeline remains limited. However, several early-phase clinical trials are ongoing, with promising mid- and …